NDC 13913-012-01 - Cambia
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13913-012
- Requested NDC
- 13913-012-01
- Package NDCs from labels
- 13913-012-01, 13913-012-03, 13913-012-02
- Manufacturer
- Assertio Therapeutics, Inc.
- Effective date
- 2024-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cambia - Assertio Therapeutics, Inc. | Assertio Therapeutics, Inc. | 2024-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13913-012-01 | Cambia | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | 9 | |
| 13913-012-02 | Cambia | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | 9 | |
| 13913-012-02 | Cambia | 9 in 1 CARTON | POWDER, FOR SOLUTION | 9 | 9 | |
| 13913-012-03 | Cambia | 9 in 1 CARTON | POWDER, FOR SOLUTION | 9 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13913-012-01 | EA - Each | 13913-012 | a4afaf38-fa08-4e82-ae9a-1cfd685736fb | 1 | 2016-11-08 |
| 13913-012-03 | EA - Each | 13913-012 | c3596580-b003-4c2f-aa16-8cf4a3bbad33 | 1 | 2016-11-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac potassium | DICLOFENAC POTASSIUM | TEVA PHARMACEUTICALS, INC. | d9685883-9d0b-81da-e053-2a95a90ab8d8 | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| ZIPSOR | DICLOFENAC POTASSIUM | Assertio Therapeutics, Inc. | c982eca0-fc41-11e1-a9c8-0002a5d5c51b | 2025-09-03 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| DICLOFENAC POTASSIUM | DICLOFENAC POTASSIUM, FILM COATED | Amici Pharma, Inc | c4ce1497-9cb1-4632-b1a2-4f61043c018d | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| KLOR-Con/EF | POTASSIUM BICARBONATE | Upsher-Smith Laboratories, Inc. | f9d85c4f-aa46-40b2-ad76-89dbf6ec8e4d | 2025-07-14 | Warnings, Adverse reactions | HM5Z15LEBN |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Golden State Medical Supply, Inc. | c2c79af6-f35e-5cdf-e053-2a95a90a4d63 | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Amici Pharma Inc. | f2908870-a517-491f-8771-4100d11b4b64 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Lifsa Drugs LLC | 90a0539a-7227-4b91-8b22-25b6f23ef35f | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Preferred Pharmaceuticals Inc. | 4f482f98-ef10-45d7-8e9f-9cf291d93092 | 2025-03-14 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Leading Pharma, LLC | 698690a7-4978-4457-b123-0a670bbab481 | 2025-03-14 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Aspartame/MSG Detox | CHELIDONIUM MAJUS, ARNICA MONTANA, PHYTOLACCA DECANDRA, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BISPHENOL A (BPA), DEXTROSE, MALTODEXTRIN, SUCRALOSE, ASPARTIC ACID, DIKETOPIPERAZINE, DOPAMINE HYDROCHLORIDE, FORMALINUM, FORMICUM ACIDUM, L-PHENYLALANINE, METHYL ALCOHOL, MONOSODIUM GLUTAMATE | Deseret Biologicals, Inc. | a1dc1bf3-db71-4550-a975-4f146fb94005 | 2025-03-11 | Warnings | 96K6UQ3ZD4 |
| diclofenac potassium | DICLOFENAC POTASSIUM | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d64537c8-e397-4d17-b95c-3092668260aa | 2025-03-10 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 08e41a9d-644c-4ac6-aba3-38d7c3f36d36 | 2025-03-07 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Marlex Pharmaceuticals, Inc. | 30c7197b-7110-d8a7-e063-6394a90addfb | 2025-03-01 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Coupler LLC | 2eead069-f954-abb2-e063-6394a90a14ff | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM TABLETS | NuCare Pharmaceuticals,Inc. | ffc41543-a353-cade-e053-6294a90a99fb | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac potassium | DICLOFENAC POTASSIUM | Camber Pharmaceuticals, Inc. | 9261a9d6-f772-41a2-ac99-8608c04c355b | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 859063 L4D5UA6CB4 |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | Bryant Ranch Prepack | 69ab6f91-5770-480c-8bd1-8c1f1f8bfdb5 | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
| Diclofenac potassium | DICLOFENAC POTASSIUM | Bryant Ranch Prepack | 8c54e404-2dbd-49cd-8235-b2a708bae563 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | L4D5UA6CB4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.